Skip to content
AnalystLens
Back to ALNYBalance Sheet

ALNYLAM PHARMACEUTICALS, INC. Long-Term Debt 2020-2022 | ALNY

Annual FY2020–FY2021 · quarterly through Q2 FY2022

Latest annual · FY2021

$675.7M

+253.3%YoY vs FY2020Source: 10-KFY2021

From $191.3M in FY2020 to $675.7M in FY2021: 3.5× in 1 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY22$677M+253.2%$678M+56.5%Not reportedNot reported
FY21$192M$433M$434M$676M+253.3%
FY20Not reportedNot reportedNot reported$191M

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

+253.3%

FY2020
$191.3M
FY2021
$675.7M

1 year selected · on the chart

Long-Term Debt History

Year-over-year comparison from 10-K annual reports

  1. $675.7M
YoY changeLatest +253.3%

1 older move runs past ±150% (largest +253.3%); point at, tap or drag across the bars to read one.

Long-Term Debt, period by period

PeriodValueChangeSource
FY2021$675.7M+253.3%10-K
FY2020$191.3M—10-K

What is long-term debt?

Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.

What is ALNYLAM PHARMACEUTICALS, INC.'s current long-term debt?

ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual long-term debt for 2021 was $675.7M, a 253.25% increase from 2020. ALNYLAM PHARMACEUTICALS, INC. long-term debt for the quarter ending June 30, 2022 was $677.7M.

What was ALNYLAM PHARMACEUTICALS, INC.'s long-term debt in 2020?

ALNYLAM PHARMACEUTICALS, INC. annual long-term debt for 2020 was $191.3M.

Company
ALNYLAM PHARMACEUTICALS, INC.
Ticker
ALNY
Sector
Healthcare
Industry
Pharmaceutical Preparations